This grant is designed for early-stage investigators (ESI) proposing highly innovative studies that align with NIH HIV/AIDS Research Priorities. The Avenir Award Program seeks to support creative individuals pursuing innovative research at the nexus of substance abuse and HIV/AIDS, with a clear description of the drug abuse link. This initiative supports both basic and clinical research approaches that promise to benefit substance-using populations affected by or at risk for HIV/AIDS. The core purpose is to reduce HIV incidence, enhance therapies, lessen the impact of comorbid conditions, and ultimately contribute to the eradication of HIV, looking towards future advancements in this critical area.
Opportunity ID: 292886
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-18-004 |
| Funding Opportunity Title: | Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 31, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Nov 13, 2019 |
| Current Closing Date for Applications: | Nov 13, 2019 |
| Archive Date: | Dec 19, 2019 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments City or township governments Special district governments State governments Private institutions of higher education Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Avenir means future in French, and the Avenir Award Program for Research on Substance Abuse and HIV/AIDS looks toward the future by supporting early stage investigators (ESI) proposing highly innovative studies that address NIH HIV/AIDS Research Priorities https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-137.html. The Avenir Award Program for Research on Substance Abuse and HIV/AIDS will support creative individuals who wish to pursue innovative research at the nexus of substance abuse and HIV/AIDS. The nexus with drug abuse should be clearly described. The Avenir Award Program for Research on Substance Abuse and HIV/AIDS will support research approaches, both basic and clinical, which have the potential to benefit substance using populations with or at risk for HIV/AIDS by reducing HIV incidence, improving therapies for HIV, reducing the impact of comorbid conditions, and ultimately, eradicating HIV. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-18-004.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-D | Use for due dates on or before January 24, 2018 | PKG00231767 | Oct 13, 2017 | Jan 24, 2018 | View | |
| FORMS-E | Use for due dates on or after January 25, 2018 | PKG00236739 | Oct 13, 2017 | Nov 13, 2019 | View |
Package 1
Mandatory forms
292886 RR_SF424_2_0-2.0.pdf
292886 PHS398_CoverPageSupplement_3_0-3.0.pdf
292886 RR_OtherProjectInfo_1_3-1.3.pdf
292886 PerformanceSite_2_0-2.0.pdf
292886 RR_KeyPersonExpanded_2_0-2.0.pdf
292886 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
292886 PHS_Inclusion_Enrollment_Report-1.0.pdf
292886 PHS_AssignmentRequestForm-1.0.pdf
Package 2
Mandatory forms
292886 RR_SF424_2_0-2.0.pdf
292886 PHS398_CoverPageSupplement_4_0-4.0.pdf
292886 RR_OtherProjectInfo_1_4-1.4.pdf
292886 PerformanceSite_2_0-2.0.pdf
292886 RR_KeyPersonExpanded_2_0-2.0.pdf
292886 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
292886 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
